ENAVATE SCIENCES GP, LLC

New York, NY · CIK 1953107 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$345.4m reported value -1.7% vs Q1 2026

7positions

100.0%in top 10

0 new 0 added 1 reduced 0 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	SIONNA THERAPEUTICS INC COM SION	SION	2,478,030	$109.0m31.56%	31.56%	Unchanged
2	ZENAS BIOPHARMA INC COM ZBIO	ZBIO	3,919,159	$99.5m28.80%	28.80%	Unchanged
3	IMMUNOME INC COM IMNM	IMNM	3,613,799	$76.6m22.17%	22.17%	Unchanged
4	BRIDGEBIO ONCOLOGY THERAPEUT COM NEW BBOT	BBOT	2,626,946	$20.0m5.80%	5.80%	Unchanged
5	COMPASS THERAPEUTICS INC COM CMPX	CMPX	7,788,150	$17.1m4.94%	4.94%	Unchanged
6	UPSTREAM BIO INC COM UPB	UPB	2,459,703	$17.0m4.93%	4.93%	Unchanged
7	CAMP4 THERAPEUTICS CORP COM CAMP	CAMP	1,425,541	$6.2m1.80%	1.80%	Reduced -765.4k	-765,379 -34.9%

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
SIONNA THERAPEUTICS INC SION · 13D · filed 2025-02-18	SION	5.6%≈ $109.0m	new	13D	2025-02-18